Skip to content

Author

Isabelle Coste

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A sensitive Interactome-based approach to characterize drug activity in living human cells.

Abnormal protein-protein interactions (PPIs) involving signaling proteins contribute to numerous human diseases. Targeting such aberrant PPIs with selective inhibitory molecules is a promising therapeutic strategy, yet assessing how many PPIs are affected by a candidate drug, and whether inhibition occurs before or aft...

Cindy Kundlacz, C. Forcet, Nawal Hajj Sleiman et al. · 0 citations
Open access Jul 2026

Non-canonical signaling hubs upon inhibition of MyD88-ERK interaction in cancer

It is demonstrated that perturbation of the ERK-MyD88 complex rewires cellular signaling into cell-autonomous hubs that coordinate caspase activation with chemokine secretion, thereby driving a program of immunogenic cancer cell death.

Nader Hussein, Najwa Skafi, Thuy Ha Pham et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.